제록스 홀딩스 주식회사
| Security | XRX / Xerox Holdings Corporation |
| Insider | Flor Colon |
This page shows the track record and history of Colon Flor
insider trades in Xerox Holdings Corporation. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Flor Colon in XRX / Xerox Holdings Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Flor Colon in XRX / Xerox Holdings Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | 2026-05-20 | 4 | Colon Flor | XRX | Restricted Stock Unit | D | -280,899 | 415,602 | ||||||
| 2026-03-13 | 2026-03-11 | 4 | Colon Flor | XRX | Common Stock | D | 1.7500 | -3,922 | -7 | 51,946 | ||||
| 2026-03-13 | 2026-03-11 | 4 | Colon Flor | XRX | Common Stock | D | 9,484 | 55,868 | ||||||
| 2026-03-13 | 2026-03-11 | 4 | Colon Flor | XRX | Restricted Stock Unit | D | -9,484 | 134,703 | ||||||
| 2026-03-13 | 2026-03-11 | 4 | Colon Flor | XRX | Common Stock | D | 1.7500 | -19,223 | -34 | 46,384 | ||||
| 2026-03-13 | 2026-03-11 | 4 | Colon Flor | XRX | Common Stock | D | 48,374 | 65,607 | ||||||
| 2026-03-13 | 2026-03-11 | 4 | Colon Flor | XRX | Restricted Stock Unit | D | -48,374 | 144,187 | ||||||
| 2026-02-06 | 2026-02-04 | 4 | Colon Flor | XRX | Common Stock | D | 2.2900 | -1,016 | -2 | 17,233 | ||||
| 2026-02-06 | 2026-02-04 | 4 | Colon Flor | XRX | Common Stock | D | 2,456 | 18,249 | ||||||
| 2026-01-21 | 2026-01-18 | 4 | Colon Flor | XRX | Common Stock | D | 2.7200 | -922 | -3 | 15,793 | ||||
| 2026-01-21 | 2026-01-18 | 4 | Colon Flor | XRX | Common Stock | D | 2,228 | 16,715 | ||||||
| 2026-01-21 | 2026-01-18 | 4 | Colon Flor | XRX | Restricted Stock Unit | D | -2,228 | 192,561 | ||||||
| 2025-05-23 | 2025-05-21 | 4 | Colon Flor | XRX | Restricted Stock Unit | D | 145,138 | 194,789 | ||||||
| 2025-03-13 | 2025-03-11 | 4 | Colon Flor | XRX | Common Stock | D | 6.1100 | -3,689 | -23 | 14,487 | ||||
| 2025-03-13 | 2025-03-11 | 4 | Colon Flor | XRX | Common Stock | D | 9,483 | 18,176 | ||||||
| 2025-03-13 | 2025-03-11 | 4 | Colon Flor | XRX | Restricted Stock Unit | D | -9,483 | 49,651 | ||||||
| 2025-01-22 | 2025-01-19 | 4 | Colon Flor | XRX | Common Stock | D | 9.3400 | -669 | -6 | 8,693 | ||||
| 2025-01-22 | 2025-01-19 | 4 | Colon Flor | XRX | Common Stock | D | 1,617 | 9,362 | ||||||
| 2025-01-22 | 2025-01-19 | 4 | Colon Flor | XRX | Restricted Stock Unit | D | -1,617 | 59,134 | ||||||
| 2025-01-22 | 2025-01-18 | 4 | Colon Flor | XRX | Common Stock | D | 9.3400 | -894 | -8 | 7,745 | ||||
| 2025-01-22 | 2025-01-18 | 4 | Colon Flor | XRX | Common Stock | D | 2,162 | 8,639 | ||||||
| 2025-01-22 | 2025-01-18 | 4 | Colon Flor | XRX | Restricted Stock Unit | D | -2,162 | 60,751 | ||||||
| 2025-01-14 | 2025-01-12 | 4 | Colon Flor | XRX | Common Stock | D | 9.0500 | -477 | -4 | 6,477 | ||||
| 2025-01-14 | 2025-01-12 | 4 | Colon Flor | XRX | Common Stock | D | 1,152 | 6,954 | ||||||
| 2025-01-14 | 2025-01-12 | 4 | Colon Flor | XRX | Restricted Stock Unit | D | -1,152 | 62,913 | ||||||
| 2024-12-17 | 2024-12-15 | 4 | Colon Flor | XRX | Restricted Stock Units | D | 8.7500 | 28,453 | 249 | 64,065 | ||||
| 2024-03-13 | 2024-03-11 | 4 | Colon Flor | XRX | Restricted Stock Unit | D | 16.8700 | 28,453 | 480 | 36,729 | ||||
| 2024-01-08 | 3 | Colon Flor | XRX | Common Stock | D | 2,723 | ||||||||
| 2024-01-08 | 3 | Colon Flor | XRX | Restricted Stock Units | D | 12,410 | ||||||||
| 2024-01-08 | 3 | Colon Flor | XRX | Performance Stock Units | D | 15,536 |
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)
